1. Home
  2. Stocks
  3. Guficbio Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Gufic BioSciences

    Small Cap
    ₹350.15
    -5.15 (-1.45%)
    27 July, 2024 10:26 BSE: 509079 NSE: GUFICBIO ISIN: INE742B01025

    Start SIP in Gufic BioSciences

    Start SIP

    Gufic BioSciences Performance

    Day Range

    • Low 347
    • High 360
    ₹ 350

    52 Week Range

    • Low 237
    • High 387
    ₹ 350
    • Open Price358
    • Previous Close355
    • Volume41851

    Gufic BioSciences Share Price

    • Over 1 Month -1.62%
    • Over 3 Month + 6.97%
    • Over 6 Month + 0.47%
    • Over 1 Year + 44.54%

    Gufic BioSciences Key Statistics

    P/E Ratio 40.8
    PEG Ratio 5.1
    Market Cap Cr
    Price to Book Ratio 6.6
    EPS 8.6
    Dividend 0
    Relative Strength Index 49.78
    Money Flow Index 30.84
    MACD Signal 1.44
    Average True Range 14.01
    Gufic BioSciences Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 195202215195173
    Operating Expenses Qtr Cr 161165176160141
    Operating Profit Qtr Cr 3436393532
    Depreciation Qtr Cr 44446
    Interest Qtr Cr 43443
    Tax Qtr Cr 77876
    Net Profit Qtr Cr 2022232118
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 809693
    Operating Expenses Annual Cr 661556
    Operating Profit Annual in Cr 146135
    Depreciation Cr 1722
    Interest Annual Cr 158
    Tax Annual Cr 3027
    Net Profit Annual Cr 8680
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -7-27
    Cash from Investing Activity Annual Cr -102-191
    Cash from Financing Annual Activity Cr 82234
    Net Cash Flow Annual Cr -2717
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 533348
    Fixed Assets Annual Cr 466329
    Total Non Current Assets Annual Cr 492397
    Total Current Assets Annual Cr 600464
    Total Assets Annual Cr 1,093861
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 5336
    ROE Annual % 1623
    ROCE Annual % 1820
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1820
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 195202215195
    Operating Expenses Qtr Cr 161165176159
    Operating Profit Qtr Cr 34363936
    Depreciation Qtr Cr 4444
    Interest Qtr Cr 4344
    Tax Qtr Cr 7787
    Net Profit Qtr Cr 20222321
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 809
    Operating Expenses Annual Cr 661
    Operating Profit Annual in Cr 146
    Depreciation Cr 17
    Interest Annual Cr 15
    Tax Annual Cr 30
    Net Profit Annual Cr 86
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -7
    Cash from Investing Activity Annual Cr -102
    Cash from Financing Annual Activity Cr 82
    Net Cash Flow Annual Cr -27
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 533
    Fixed Assets Annual Cr 466
    Total Non Current Assets Annual Cr 492
    Total Current Assets Annual Cr 600
    Total Assets Annual Cr 1,093
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 53
    ROE Annual % 16
    ROCE Annual % 18
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 18
    Invest in Gufic BioSciences

    Gufic BioSciences Technicals

    EMA & SMA

    Current Price
    ₹350.15
    -5.15 (-1.45%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹351.28
    • 50 Day
    • ₹345.10
    • 100 Day
    • ₹334.46
    • 200 Day
    • ₹316.40
    • 20 Day
    • ₹354.48
    • 50 Day
    • ₹345.82
    • 100 Day
    • ₹326.65
    • 200 Day
    • ₹318.11

    Gufic BioSciences Resistance and Support

    PIVOT
    ₹352.27
    Resistance
    First Resistance 357.58
    Second Resistance 365.02
    Third Resistance 370.33
    RSI 49.78
    MFI 30.84
    MACD Single Line 1.44
    MACD -0.09
    Support
    First Support 344.83
    Second Support 339.52
    Third Supoort 332.08

    Gufic BioSciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 56,994 3,168,296 55.59
    Week 71,898 3,493,504 48.59
    1 Month 86,364 4,467,610 51.73
    6 Month 137,312 6,618,450 48.2

    Gufic BioSciences Result Highlights

    Gufic BioSciences Synopsis

    NSE-Medical-Generic Drugs

    Gufic Biosciences Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 690.62 Cr. and Equity Capital is Rs. 9.69 Cr. for the Year ended 31/03/2023. Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519.
    Market Cap 3,511
    Sales 807
    Shares in Float 2.71
    No of funds 19
    Yield 0.03
    Book Value 6.59
    U/D Vol ratio 1.2
    LTDebt / Equity 29
    Alpha 0.03
    Beta 0.97

    Gufic BioSciences Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23
    Promoters 72.51%72.51%72.51%
    Mutual Funds 2.3%2.08%1.6%
    Foreign Portfolio Investors 0.23%0.12%0.47%
    Individual Investors 16.36%16.72%16.85%
    Others 8.6%8.57%8.57%

    Gufic BioSciences Management

    Name Designation
    Mr. Jayesh P Choksi Chairman & Managing Director
    Mr. Pranav J Choksi WholeTime Director & CEO
    Mr. Pankaj J Gandhi Whole Time Director
    Mr. Dilip B Ghosh Whole Time Director
    Dr. Balram H Singh Non Exe.Non Ind.Director
    Mr. Shreyas K Patel Independent Director
    Mr. Shrirang V Vaidya Independent Director
    Dr. Anu S Auora Independent Director
    Dr. Rabi N Sahoo Independent Director
    Mr. Gopal M Daptari Independent Director

    Gufic BioSciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Gufic BioSciences Corporate Action

    Date Purpose Remarks
    2024-05-29 Audited Results & Final Dividend
    2024-02-14 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-11 Quarterly Results & ESOP
    2023-05-29 Audited Results & Final Dividend

    Gufic BioSciences MF Shareholding

    Name Amount(cr)
    ICICI Prudential Regular Savings Fund Growth 3,355
    SBI Healthcare Opportunities Fund Regular Payout Inc Dist cum Cap Wdrl 2,760
    Motilal Oswal Small Cap Fund Regular Growth 1,956
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 1,168
    Groww Nifty Total Market Index Fund Regular Growth 175

    Gufic BioSciences FAQs

    What is Share Price of Gufic BioSciences ?

    Gufic BioSciences share price is ₹350 As on 27 July, 2024 | 10:12

    What is the Market Cap of Gufic BioSciences ?

    The Market Cap of Gufic BioSciences is ₹3511.2 Cr As on 27 July, 2024 | 10:12

    What is the P/E ratio of Gufic BioSciences ?

    The P/E ratio of Gufic BioSciences is 40.8 As on 27 July, 2024 | 10:12

    What is the PB ratio of Gufic BioSciences ?

    The PB ratio of Gufic BioSciences is 6.6 As on 27 July, 2024 | 10:12

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.